|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proximagen Neuroscience plc securities are currently only traded on AIM, although other exchanges and platforms remain subject to review. There are currently no restrictions on the transfer of securities.
The below information is accurate as of 16 July 2007
|
|
|
| Number of shares in issue | |
|
| Number of shares not in public hands | |
|
|
|
|
| IP2IPO Management II Limited | |
|
|
|
|
|
|
|
|
|
|
| New Star Asset Management | |
|
| Gartmore Investment
Management | |
|
|
|
|
|
|
|
| Blackrock Investment Management | |
|
| Henderson Global Investors | |
|
|
|
|
| IP2IPO Management Limited | |
|
|
|
|
|
|
|
|
|
